Original Article
Increase of CD3+CD7− T cells in bone marrow predicts invasion in patients with T-cell non-Hodgkin’s lymphoma
Translational Cancer Research
2022;
11
(6)
:1463-1471
.
(29 June 2022)
Comparison of efficacy and safety of bevacizumab biosimilar and original bevacizumab in non-squamous non-small cell lung cancer: a systematic review and meta-analysis
Translational Cancer Research
2022;
11
(6)
:1472-1482
.
(29 June 2022)
Analysis of clinical outcomes of patients with primary rare carcinoma of Bartholin gland: six case series report and review of the literature
Translational Cancer Research
2022;
11
(6)
:1483-1487
.
(29 June 2022)
Comprehensive analysis of lower mitochondrial complex I expression is associated with cell metastasis of clear cell renal cell carcinoma
Translational Cancer Research
2022;
11
(6)
:1488-1502
.
(29 June 2022)
Characteristics and significance of T lymphocyte subsets in peripheral blood of osteosarcoma mice
Translational Cancer Research
2022;
11
(6)
:1503-1509
.
(29 June 2022)
Construction and validation of a pyroptosis-related gene signature in hepatocellular carcinoma based on RNA sequencing
Translational Cancer Research
2022;
11
(6)
:1510-1522
.
(29 June 2022)
Identification of an immune-related gene pair signature in breast cancer
Translational Cancer Research
2022;
11
(6)
:1523-1533
.
(29 June 2022)
Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in gastric cancer with multi-organ metastases
Translational Cancer Research
2022;
11
(6)
:1534-1551
.
(29 June 2022)
Elevated RECQL1 expression predicts poor prognosis and associates with tumor immune infiltration in low-grade glioma
Translational Cancer Research
2022;
11
(6)
:1552-1564
.
(29 June 2022)
miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression
Translational Cancer Research
2022;
11
(6)
:1565-1575
.
(29 June 2022)
N6-methyladenosine methylation related immune biomarkers correlates with clinicopathological characteristics and prognosis in clear cell renal cell carcinoma
Translational Cancer Research
2022;
11
(6)
:1576-1586
.
(29 June 2022)
The association between ephrin receptor-A1 expression and survival in patients with cancer: a meta-analysis
Translational Cancer Research
2022;
11
(6)
:1587-1594
.
(29 June 2022)
Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1
Translational Cancer Research
2022;
11
(6)
:1595-1602
.
(29 June 2022)
Diagnostic value of objective VELscope fluorescence methods in distinguishing oral cancer from oral potentially malignant disorders (OPMDs)
Translational Cancer Research
2022;
11
(6)
:1603-1615
.
(29 June 2022)
Effects of heavy ions (12C6+) on malignant melanoma B16F10 cells
Translational Cancer Research
2022;
11
(6)
:1616-1629
.
(29 June 2022)
Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy
Translational Cancer Research
2022;
11
(6)
:1630-1643
.
(29 June 2022)
Expression of HIF-1α, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinoma
Translational Cancer Research
2022;
11
(6)
:1644-1651
.
(29 June 2022)
Is there different prognosis between cervical endometrioid adenocarcinoma and ordinary cervical adenocarcinoma in a propensity score matching study based on the surveillance, epidemiology, and end results (SEER) database?
Translational Cancer Research
2022;
11
(6)
:1652-1664
.
(29 June 2022)
Bioinformatics analysis based on ferroptosis-related lncRNAs: construction of a clinical prognostic model for nasopharyngeal carcinoma and correlation analysis
Translational Cancer Research
2022;
11
(6)
:1665-1677
.
(29 June 2022)
Systematic review and meta-analysis of the efficacy and safety of high-intensity focused ultrasound combined with transarterial chemoembolization and transarterial chemoembolization alone in the treatment of liver cancer
Translational Cancer Research
2022;
11
(6)
:1678-1688
.
(29 June 2022)
Diagnostic test of dynamic computed tomography in early gastrointestinal lymphoma and precancerous lesions
Translational Cancer Research
2022;
11
(6)
:1689-1696
.
(29 June 2022)
Short-term outcomes of neoadjuvant sintilimab with chemotherapy in stage III non-small cell lung cancer: a case series
Translational Cancer Research
2022;
11
(6)
:1697-1704
.
(29 June 2022)
Effect of taurine on the proliferation, apoptosis and MST1/Hippo signaling in prostate cancer cells
Translational Cancer Research
2022;
11
(6)
:1705-1712
.
(29 June 2022)
Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis
Translational Cancer Research
2022;
11
(6)
:1713-1721
.
(29 June 2022)
Screening diagnostic markers for acute myeloid leukemia based on bioinformatics analysis
Translational Cancer Research
2022;
11
(6)
:1722-1729
.
(29 June 2022)
Screening and expression verification of key genes in cutaneous squamous cell carcinoma
Translational Cancer Research
2022;
11
(6)
:1730-1739
.
(29 June 2022)
Experience with flap repair after vulvar carcinoma resection: a retrospective observational study of 26 cases
Translational Cancer Research
2022;
11
(6)
:1740-1749
.
(29 June 2022)
Benzene exposure increases the risk of non-Hodgkin’s lymphoma: a systematic review and meta-analysis of observational studies
Translational Cancer Research
2022;
11
(6)
:1750-1761
.
(29 June 2022)
Relationship between positive margin and residual/recurrence after excision of cervical intraepithelial neoplasia: a systematic review and meta-analysis
Translational Cancer Research
2022;
11
(6)
:1762-1769
.
(29 June 2022)
The efficacy and safety of apatinib in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis
Translational Cancer Research
2022;
11
(6)
:1770-1780
.
(29 June 2022)
Hesperetin ameliorates glioblastoma by inhibiting proliferation, inducing apoptosis, and suppressing metastasis
Translational Cancer Research
2022;
11
(6)
:1781-1794
.
(29 June 2022)
Review Article
Reporting quality of clinical practice guidelines on head and neck cancer: a systematic review
Translational Cancer Research
2022;
11
(6)
:1795-1805
.
(29 June 2022)
Case Report
A case report of acquired immunodeficiency syndrome (AIDS)-related refractory Burkitt lymphoma got complete remission by multidisciplinary and multi-target combined therapy
Translational Cancer Research
2022;
11
(6)
:1806-1812
.
(29 June 2022)
Severe side effects caused by parenteral nutrition therapy with fat emulsion (10%)/amino acids (15)/glucose (20%) injection: 2 case reports
Translational Cancer Research
2022;
11
(6)
:1813-1818
.
(29 June 2022)
The effect of afatinib in a pretreated patient with invasive mucinous adenocarcinoma of the lung harboring HER2 YVMA insertion: a case report
Translational Cancer Research
2022;
11
(6)
:1819-1823
.
(29 June 2022)
Gastroparesis as a significant gastrointestinal adverse event during intensive chemotherapy for solid caner: a case report
Translational Cancer Research
2022;
11
(6)
:1824-1828
.
(29 June 2022)
EDP-M plus sintilimab in the treatment of adrenocortical carcinoma: a case report
Translational Cancer Research
2022;
11
(6)
:1829-1835
.
(29 June 2022)
Case report: sequential use of almonertinib based on the EGFR exon 20 insertion mutation achieves long-term control for advanced non-small cell lung cancer patients
Translational Cancer Research
2022;
11
(6)
:1836-1843
.
(29 June 2022)
Primary pulmonary choriocarcinoma in male: report a case with genetic testing and review of the literature
Translational Cancer Research
2022;
11
(6)
:1844-1849
.
(29 June 2022)
Case report: NUT carcinoma in an elderly woman with unique morphology and immunophenotype highlights a diagnostic pitfall
Translational Cancer Research
2022;
11
(6)
:1850-1860
.
(29 June 2022)
